Literature DB >> 23608216

[Garre's chronic sclerosing osteomyelitis with sacral involvement in a child].

S Franco-Jiménez1, J F Romero-Aguilar, S Bervel-Clemente, M Martínez-Váquez, N Alvarez-Benito, P Grande-Gutiérrez, R G Maldonado-Yanza.   

Abstract

We report the case of a 6 year old patient who started with abdominal pain and left sciatica, which did not improve after applying symptomatic treatment. A complete analytical and imaging study was performed, which showed a lesion in left S1 corresponding to Garrè's chronic diffuse sclerosing osteomyelitis. The diagnosis was confirmed by biopsy of the lesion. Treatment was established with corticosteroids and anti-inflammatory drugs, obtaining a clinical improvement, although in the follow-up imaging tests 2 years after the onset of the symptoms, the lesion persists but with a significant reduction in its size.
Copyright © 2012 SECOT. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23608216     DOI: 10.1016/j.recot.2012.11.003

Source DB:  PubMed          Journal:  Rev Esp Cir Ortop Traumatol        ISSN: 1888-4415


  4 in total

1.  Garre's sclerosing osteomyelitis caused by salmonella group D in a patient with systemic lupus erythematosus: an unusual complication.

Authors:  Claudia Elera-Fitzcarrald; José L Alfaro-Lozano; César A Pastor-Asurza
Journal:  Clin Rheumatol       Date:  2015-10-29       Impact factor: 2.980

2.  Sciatica in the young.

Authors:  Sim Sai Tin; Viroj Wiwanitkit
Journal:  Asian Spine J       Date:  2014-10-18

3.  A comparison of the vancomycin calcium sulfate implantation versus fenestration decompression for the treatment of sclerosing osteomyelitis.

Authors:  Haotian Hua; Xinwei Wang; Jiangang Guo; Lei Zhang; Zairan Guo; Jiangfei Chen
Journal:  BMC Musculoskelet Disord       Date:  2021-11-29       Impact factor: 2.362

4.  A 53-year-old man with a sclerosing rib lesion: A case report.

Authors:  Shucai Bai; Huafeng Zhang; Zhijun Li; Dong Li; Hui Li
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.